6 [13] H. Grandjean, D. Larroque, and S. Levi, “The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study,” American Journal of Obstetrics and Gynecol- ogy, vol. 181, no. 2, pp. 446–454, 1999. [14] E. Montan˜a, M. J. Khoury, J. D. Cragan, S. Sharma, P. Dhar, and D. Fyfe, “Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well deﬁned birth population, Atlanta, Georgia, 1990–1994,” Journal of the American College of Cardiology, vol. 28, no. 7, pp. 1805–1809, 1997. [15] C. Chew, S. Stone, S. M. Donath, and D. J. Penny, “Impact of antenatal screening on the presentation of infants with congenital heart disease to a cardiology unit,” Journal of Paediatrics and Child Health, vol. 42, no. 11, pp. 704–708, 2006. [16] I. Stiimpﬂen, A. Stumpﬂen, M. Wimmer, and G. Bernaschek, “Eﬀect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congeni- tal heart disease,” Obstetrical & Gynecological Survey, vol. 52, no. 3, pp. 163–165, 1997. [17] G. Wernovsky, “Improving neurologic and quality-of-life outcomes in children with congenital heart disease: past, present, and future,” Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 2, pp. 240–242.e2, 2008. [18] L. de Crespigny and R. Dredge, Which Tests for my Unborn Baby? Oxford University Press, Melbourne, Australia, 1997. [19] S. Menahem and J. Grimwade, “Pre-natal counselling-helping couples make decisions following the diagnosis of severe heart disease,” Early Human Development, vol. 81, no. 7, pp. 601– 607, 2005. [20] L. J. de Crespigny and J. Savulescu, “Pregnant women with fetal abnormalities: the forgotten people in the abortion debate,” Medical Journal of Australia, vol. 188, no. 2, pp. 100– 103, 2008. [21] L. D. Allan and I. C. Huggon, “Counselling following a diagnosis of congenital heart disease,” Prenatal Diagnosis, vol. 24, no. 13, pp. 1136–1142, 2004. [22] B. L. Shaﬀer, A. B. Caughey, and M. E. Norton, “Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy,” Prenatal Diagnosis, vol. 26, no. 8, pp. 667–671, 2006. [23] M. I. Evans, M. A. Sobiecki, E. L. Krivchenia, et al., “Parental decisions to terminate/continue following abnormal cytoge- netic prenatal diagnosis; “what” is still more important than “when”,” American Journal of Medical Genetics, vol. 61, no. 4, pp. 353–355, 1996. [24] S. Menahem and J. Grimwade, “Pregnancy termination fol- lowing prenatal diagnosis of serious heart disease in the fetus,” Early Human Development, vol. 73, no. 1-2, pp. 71–78, 2003. [25] S. D. Brown, R. D. Truog, J. A. Johnson, and J. L. Ecker, “Do diﬀerences in the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists positions on the ethics of maternal-fetal interventions reﬂect subtly divergent professional sensitivities to pregnant women and fetuses?” Pediatrics, vol. 117, no. 4, pp. 1382–1387, 2006. [26] D. Maxwell, L. Allan, and M. J. Tynan, “Balloon dilatation of the aortic valve in the fetus: a report of two cases,” British Heart Journal, vol. 65, no. 5, pp. 256–258, 1991. [27] J. M. Simpson and G. K. Sharland, “Natural history and outcome of aortic stenosis diagnosed prenatally,” Heart, vol. 77, no. 3, pp. 205–210, 1997. [28] G. Tulzer, W. Arzt, R. C. G. Franklin, P. V. Loughna, R. Mair, and H. M. Gardiner, “Fetal pulmonary valvuloplasty for International Journal of Pediatrics critical pulmonary stenosis or atresia with intact septum,” The Lancet, vol. 360, no. 9345, pp. 1567–1568, 2002. [29] A. D. Lyerly, E. A. Gates, R. C. Cefalo, and J. Sugarman, “Toward the ethical evaluation and use of maternal-fetal surgery,” Obstetrics and Gynecology, vol. 98, no. 4, pp. 689–697, 2001. [30] A. Malhotra, S. Menahem, P. Shekleton, and L. Gillam, “Medical and ethical considerations in twin pregnancies discordant for serious cardiac disease,” Journal of Perinatology, vol. 29, no. 10, pp. 662–667, 2009.